Moreover, Devasahayam et al. demonstrated that during maximal exercise, MS patients exhibited lower levels of IL-6 [29], suggesting that reducing IL-6 or its effects may be possible through methods other than disease-modifying therapy. Here, IL6 is linked to myeloid sarcoma.